Member Profile

Formosa Laboratories is a global API supplier. We provides GMP one-stop-shop CDMO services. The services ranges from small-molecule and polymer API to in-house payload-linker CMC services and antibody bio-conjugation for Antibody Drug Conjugate (ADC). We also offer aseptic liquid filling and lyophilization of both cytotoxic and non-cytotoxic injectables.

Company Milestones

   2021 Passed GMP inspection by TFDA for packaging and labeling of medicinal products. Passed GDP inspection by TFDA for medicinal products.
   2018 Formosa’s customer in mainland China get the 1st Montelukast GQCE approval in Chinese mainland.
   2013 Passed joint GMP inspection by EDQM and BGC Hamburg
   2010 Passed 1st PAI for Mycophenolate Mofetil by COFEPRIS of Mexico
   2009 Passed 1st PAI for Gadodiamide by PMDA of Japan
   2007 Passed 1st GMP inspection by BSG of Hamburg, Germany
   2004 Passed 1st PAI by US FDA for Leflunomide API